What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Fungus
- Antibiotics
Microbiology, Aspergillosis, Pharmacology, Mycosis and Aspergillus are his primary areas of study.
His In vivo research extends to Microbiology, which is thematically connected.
His biological study spans a wide range of topics, including Cancer, Amphotericin B and Gliotoxin.
The Pharmacology study which covers Caspofungin that intersects with In vitro and Calcineurin.
He interconnects Aspergillus fumigatus, Intensive care medicine and Pathology in the investigation of issues within Mycosis.
His work in Aspergillus addresses issues such as Azole, which are connected to fields such as Zygomycosis, Minimum inhibitory concentration and Mucormycosis.
His most cited work include:
- Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: Evidence of Concentration-Dependent Activity (185 citations)
- Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: Evidence of Concentration-Dependent Activity (185 citations)
- Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa (159 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Microbiology, Pharmacology, Fluconazole, Voriconazole and Caspofungin.
Antifungal is closely connected to In vitro in his research, which is encompassed under the umbrella topic of Microbiology.
His research in Pharmacology intersects with topics in Potency and In vivo.
He works mostly in the field of Fluconazole, limiting it down to concerns involving Cryptococcus neoformans and, occasionally, Cryptococcosis.
His work deals with themes such as Itraconazole, Aspergillosis and Lung, which intersect with Voriconazole.
His Aspergillosis study incorporates themes from Aspergillus fumigatus, Mycosis and Aspergillus.
He most often published in these fields:
- Microbiology (58.61%)
- Pharmacology (27.48%)
- Fluconazole (18.54%)
What were the highlights of his more recent work (between 2017-2021)?
- Microbiology (58.61%)
- Fluconazole (18.54%)
- Posaconazole (11.26%)
In recent papers he was focusing on the following fields of study:
Nathan P. Wiederhold mainly investigates Microbiology, Fluconazole, Posaconazole, In vivo and Voriconazole.
His research on Microbiology frequently connects to adjacent areas such as Fusarium.
His Fluconazole research is multidisciplinary, incorporating perspectives in Coccidioides immitis, Azole, Candida auris and Candida albicans.
His Azole research integrates issues from Aspergillus fumigatus and Aspergillosis.
His work in In vivo covers topics such as Pharmacology which are related to areas like Kidney.
His Voriconazole research includes elements of Itraconazole, Terbinafine and Myeloid leukemia.
Between 2017 and 2021, his most popular works were:
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (121 citations)
- Coelomycetous Dothideomycetes with emphasis on the families Cucurbitariaceae and Didymellaceae. (52 citations)
- Fungal infections in animals: A patchwork of different situations (41 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Fungus
- Gene
The scientist’s investigation covers issues in Microbiology, Caspofungin, In vivo, Fluconazole and Posaconazole.
Many of his studies on Microbiology involve topics that are commonly interrelated, such as Aspergillosis.
His Caspofungin research is multidisciplinary, relying on both Intraperitoneal injection, Candida glabrata, Echinocandin and Kidney.
His research integrates issues of Inoculation, In vitro, Central nervous system, Coccidioides immitis and Pharmacology in his study of In vivo.
The various areas that Nathan P. Wiederhold examines in his Fluconazole study include Candida auris and Candida albicans.
His Posaconazole research incorporates elements of Aspergillus, Amphotericin B deoxycholate, Guideline, Disease management and Rare disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
